Benlysta Will Garner Sales of More Than $500 Million in 2018 in the Systemic Lupus Erythematosus Drug Market
Advertisement
Following Its Expected Approval, Benlysta Will Be the First Agent to Launch for the Disease in More Than 40 Years, According to New Findings from Decision Resources